SILO PHARMA, INC. Interest Income, Other
SILO PHARMA, INC. (SILO) reported Interest Income, Other of $1.21 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2022-03-28
- SILO PHARMA, INC. interest income, other for the quarter ending 2020-12-31 was $2.75K.
- SILO PHARMA, INC. interest income, other for the quarter ending 2020-09-30 was $2.82K.
- SILO PHARMA, INC. interest income, other for fiscal 2021 was $1.21K, a 89.52% decline from fiscal 2020.
- SILO PHARMA, INC. interest income, other for fiscal 2020 was $11.54K.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month |
|---|---|---|---|---|
| 2021-12-31 | $1.21K 10-K · filed 2022-03-28 | |||
| 2020-12-31 | $2.75K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $5.57K derived: sum of 2 quarters · filed 2022-03-28 | $11.54K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $2.82K 10-Q · filed 2021-11-10 | $8.79K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |